These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
426 related articles for article (PubMed ID: 25063027)
1. GPER mediated estradiol reduces miR-148a to promote HLA-G expression in breast cancer. Tao S; He H; Chen Q; Yue W Biochem Biophys Res Commun; 2014 Aug; 451(1):74-8. PubMed ID: 25063027 [TBL] [Abstract][Full Text] [Related]
2. Estradiol induces HOTAIR levels via GPER-mediated miR-148a inhibition in breast cancer. Tao S; He H; Chen Q J Transl Med; 2015 Apr; 13():131. PubMed ID: 25928008 [TBL] [Abstract][Full Text] [Related]
3. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells. Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-424 suppresses estradiol-induced cell proliferation via targeting GPER in endometrial cancer cells. Zhang H; Wang X; Chen Z; Wang W Cell Mol Biol (Noisy-le-grand); 2015 Nov; 61(7):96-101. PubMed ID: 26638889 [TBL] [Abstract][Full Text] [Related]
5. Estrogenic gper signaling regulates mir144 expression in cancer cells and cancer-associated fibroblasts (cafs). Vivacqua A; De Marco P; Santolla MF; Cirillo F; Pellegrino M; Panno ML; Abonante S; Maggiolini M Oncotarget; 2015 Jun; 6(18):16573-87. PubMed ID: 26030000 [TBL] [Abstract][Full Text] [Related]
6. GPER activates Notch signaling in breast cancer cells and cancer-associated fibroblasts (CAFs). Pupo M; Pisano A; Abonante S; Maggiolini M; Musti AM Int J Biochem Cell Biol; 2014 Jan; 46():56-67. PubMed ID: 24275097 [TBL] [Abstract][Full Text] [Related]
7. GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells. Vivacqua A; Romeo E; De Marco P; De Francesco EM; Abonante S; Maggiolini M Breast Cancer Res Treat; 2012 Jun; 133(3):1025-35. PubMed ID: 22147081 [TBL] [Abstract][Full Text] [Related]
8. Regulation of ERRalpha gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by g protein-coupled receptor GPR30/GPER-1. Li Y; Birnbaumer L; Teng CT Mol Endocrinol; 2010 May; 24(5):969-80. PubMed ID: 20211987 [TBL] [Abstract][Full Text] [Related]
9. NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer. Meng R; Qin Q; Xiong Y; Wang Y; Zheng J; Zhao Y; Tao T; Wang Q; Liu H; Wang S; Jiang WG; He J Oncotarget; 2016 Aug; 7(34):54983-54997. PubMed ID: 27448983 [TBL] [Abstract][Full Text] [Related]
10. SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer. Santolla MF; Avino S; Pellegrino M; De Francesco EM; De Marco P; Lappano R; Vivacqua A; Cirillo F; Rigiracciolo DC; Scarpelli A; Abonante S; Maggiolini M Cell Death Dis; 2015 Jul; 6(7):e1834. PubMed ID: 26225773 [TBL] [Abstract][Full Text] [Related]
11. GPER mediates activation of HIF1α/VEGF signaling by estrogens. De Francesco EM; Pellegrino M; Santolla MF; Lappano R; Ricchio E; Abonante S; Maggiolini M Cancer Res; 2014 Aug; 74(15):4053-64. PubMed ID: 24894716 [TBL] [Abstract][Full Text] [Related]
12. Dynamic monitoring of GPER-mediated estrogenic effects in breast cancer associated fibroblasts: An alternative role of estrogen in mammary carcinoma development. Luo H; Liu M; Luo S; Yu T; Wu C; Yang G; Tu G Steroids; 2016 Aug; 112():1-11. PubMed ID: 27016131 [TBL] [Abstract][Full Text] [Related]
13. miR-191/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer. Tian X; Zhang Z IUBMB Life; 2018 Jan; 70(1):71-80. PubMed ID: 29247596 [TBL] [Abstract][Full Text] [Related]
14. The G-protein-coupled estrogen receptor, a gene co-expressed with ERα in breast tumors, is regulated by estrogen-ERα signalling in ERα positive breast cancer cells. Pal U; Manjegowda MC; Singh N; Saikia S; Philip BS; Jyoti Kalita D; Kumar Rai A; Sarma A; Raphael V; Modi D; Chandra Kataki A; Mukund Limaye A Gene; 2023 Aug; 877():147548. PubMed ID: 37279863 [TBL] [Abstract][Full Text] [Related]
15. Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth. Catalano S; Giordano C; Panza S; Chemi F; Bonofiglio D; Lanzino M; Rizza P; Romeo F; Fuqua SA; Maggiolini M; Andò S; Barone I Breast Cancer Res Treat; 2014 Jul; 146(2):273-85. PubMed ID: 24928526 [TBL] [Abstract][Full Text] [Related]
16. G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1. Liu C; Liao Y; Fan S; Tang H; Jiang Z; Zhou B; Xiong J; Zhou S; Zou M; Wang J Med Oncol; 2015 Apr; 32(4):104. PubMed ID: 25744245 [TBL] [Abstract][Full Text] [Related]
17. Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER. Zekas E; Prossnitz ER BMC Cancer; 2015 Oct; 15():702. PubMed ID: 26470790 [TBL] [Abstract][Full Text] [Related]
18. G protein‑coupled estrogen receptor/miR‑148a/human leukocyte antigen‑G signaling pathway mediates cell apoptosis of ovarian endometriosis. He SZ; Li J; Bao HC; Wang MM; Wang XR; Huang X; Li FH; Zhang W; Xu AL; Fang HC; Sheng YX Mol Med Rep; 2018 Jul; 18(1):1141-1148. PubMed ID: 29845209 [TBL] [Abstract][Full Text] [Related]
19. MiR-206 inhibits estrogen signaling and ovarian cancer cell migration without affecting GPER. Boscaro C; Ramaschi GE; Trevisi L; Cignarella A; Bolego C Life Sci; 2023 Nov; 333():122135. PubMed ID: 37778413 [TBL] [Abstract][Full Text] [Related]
20. Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells. Rigiracciolo DC; Santolla MF; Lappano R; Vivacqua A; Cirillo F; Galli GR; Talia M; Muglia L; Pellegrino M; Nohata N; Di Martino MT; Maggiolini M J Exp Clin Cancer Res; 2019 Feb; 38(1):58. PubMed ID: 30728047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]